101
|
Wu F, Hu C, Zhao L, Zhou C, Wang H, Jiang S. P30.12 The Impact of Pacemaker and Methylprednisolone Pulse Therapy on Immune-Related Myocarditis With Complete Atrioventricular Block. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.657] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
102
|
Deng P, Tan J, Hu C, Cao L, Yang H, Li M, Gu Q, Li Y, An J, Han-Zhang H. P76.20 The Predictive Values of Non-Resistant Nncommon EGFR Mutations in Advanced Non-Small Cell Lung Cancer Patients. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.1077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
103
|
Wu F, Hu C, Huang Y, Pu X, Liu C, Liu X, Ma F, Zhao L, Shu L, Pan Y, Zeng Y. FP01.02 The Efficacy of Postoperative Radiotherapy in IIIA-N2 Non-Squamous NSCLC with Different EGFR Mutation Status: A Retrospective Analysis. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
104
|
Deng P, Yang H, Chen C, Hu C, Cao L, Gu Q, An J, Li B, Tang Y, Meng J, Qin L, Feng J. P48.05 Anlotinib Plus Platinum-Etoposide in 1st-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Single-Arm Phase II Trial. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.875] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
105
|
Tang B, Han Y, Liu X, Zhang H, Li M, Hu C, Zhang L. Medical services provided on the ' Harmonious Mission-2017' Peace Ark from China. BMJ Mil Health 2021; 169:e44-e50. [PMID: 33547191 PMCID: PMC10176340 DOI: 10.1136/bmjmilitary-2020-001659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Revised: 12/12/2020] [Accepted: 12/17/2020] [Indexed: 11/04/2022]
Abstract
INTRODUCTION The Chinese Naval ship Peace Ark provided humanitarian medical services to people in eight low-income countries in Africa and Asia during the 2017 "Harmonious Mission'. The expedition lasted 155 days. Our study aimed to analyse the details of the medical services provided including outpatient care, medical patrol, operations, examinations and medications. METHOD The patient demographic data and medical information were extracted from electronic medical records. The diagnoses and procedures aboard were coded by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). The sociodemographic data of the medical staff aboard were collected via questionnaire. Descriptive statistics and statistical software (SAS, V.9.4) were used to analyse the data. RESULTS In total, 115 Chinese military medical personnel participated in the mission, completing a total of 50 758 outpatient visits, 10 232 medical patrols and 252 operations. The five most frequently used outpatient departments were ophthalmology, general surgery, general internal medicine, orthopaedics and traditional Chinese medicine. The five most common operations were lipoma excision, cataract extraction, skin tissue removal (such as warts and cysts), pterygium transposition and herniorrhaphy. CONCLUSIONS Our study revealed the medical services in demand during the 'Harmonious Mission-2017'. It is essential to report their experiences so that future ventures can provide medical services more effectively.
Collapse
|
106
|
Hazell SZ, Fu W, Hu C, Voong KR, Lee B, Peterson V, Feliciano JL, Nicholas LH, McNutt TR, Han P, Hales RK. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann Oncol 2021; 31:96-102. [PMID: 31912803 DOI: 10.1016/j.annonc.2019.10.006] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2019] [Revised: 09/29/2019] [Accepted: 10/08/2019] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Advances in lung cancer therapy have resulted in improved clinical outcomes. Unfortunately, advances can come at a financial cost to patients and their families that poses a significant risk to overall quality of life (QoL). Financial distress has been shown to be associated with increased symptom burden and decreased treatment compliance but the magnitude of financial distress is not well characterized in lung cancer populations. PATIENTS AND METHODS Patients with stage II-IV newly diagnosed lung cancer and starting first-line therapy were recruited at a tertiary academic institution between July 2018 and April 2019. The comprehensive score for financial toxicity (COST) was used to assess financial toxicity and the Functional Assessment of Cancer Therapy-Lung (FACT-L) was used to assess QoL. Associations between financial toxicity and baseline variables were assessed using multivariable linear regression and correlations were assessed using the Pearson correlation. RESULTS In this study, 143 consecutive patients were approached and 91.6% agreed to participate (N = 131). The median age was 65 years (35-90); 52.7% were male (n = 69), and 75.6% were white (n = 99). The inability to afford basic necessities and having <1 month of savings was associated with increased financial toxicity (P < 0.001) after adjusting for other factors such as age, race, insurance, and income. There was also a trend toward increased financial toxicity among those who were employed but on sick leave (P = 0.06). Increased financial toxicity was correlated with a decrease in QoL (correlation coefficient 0.41, P < 0.001). Patients' anticipated out-of-pocket (OOP) expenses for the upcoming 6 months ranged from $0 to $50 000 (median $2150). However, there was no correlation between anticipated OOP expenses and either financial toxicity or QoL. CONCLUSIONS These data identify key factors for identifying at-risk patients and builds a framework for exploring the benefit of financial counseling interventions, which may improve QoL and oncologic outcomes.
Collapse
|
107
|
Wang J, Lu S, Hu C, Sun Y, Yang K, Chen M, Zhao J, Yu G, Zhou X, Feng G, Pan Y, Yu Y, Zhang J, Liang L, Lin X, Cui J. OA03.04 Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small Cell Lung Cancer. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2020.10.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
108
|
Shi J, Chen M, Wei D, Hu C, Luo J, Wang H, Zhang X, Xie C. Anti-noise diffractive neural network for constructing an intelligent imaging detector array. OPTICS EXPRESS 2020; 28:37686-37699. [PMID: 33379598 DOI: 10.1364/oe.405798] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2020] [Accepted: 11/19/2020] [Indexed: 06/12/2023]
Abstract
To develop an intelligent imaging detector array, a diffractive neural network with strong robustness based on the Weight-Noise-Injection training is proposed. According to layered diffractive transformation under existing several errors, an accurate and fast object classification can be achieved. The fact that the mapping between the input image and the label in Weight-Noise-Injection training mode can be learned, means that the prediction of the optical network being insensitive to disturbances so as to improve its noise resistance remarkably. By comparing the accuracy under different noise conditions, it is verified that the proposed model can exhibit a higher accuracy.
Collapse
|
109
|
Xu N, Han B, Jiao S, Hu C, Mislang A, Coward J, Cooper A, Underhill C, Xia Y, Xia D, Jin X, Wang Z, Li B. 31P Integrated safety analysis of anti-programmed cell death-1 (PD-1) antibody penpulimab in advanced solid tumour or lymphoma. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
110
|
Chen M, Shao Q, He W, Wei D, Hu C, Shi J, Liu K, Wang H, Xie C, Zhang X. Electrically Controlled Liquid Crystal Microlens Array Based on Single-Crystal Graphene Coupling Alignment for Plenoptic Imaging. MICROMACHINES 2020; 11:E1039. [PMID: 33256175 PMCID: PMC7760086 DOI: 10.3390/mi11121039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/03/2020] [Revised: 11/19/2020] [Accepted: 11/25/2020] [Indexed: 11/21/2022]
Abstract
As a unique electric-optics material, liquid crystals (LCs) have been used in various light-control applications. In LC-based light-control devices, the structural alignment of LC molecules is of great significance. Generally, additional alignment layers are required for LC lens and microlens, such as rubbed polyimide (PI) layers or photoalignment layers. In this paper, an electrically controlled liquid crystal microlens array (EC-LCMLA) based on single-crystal graphene (SCG) coupling alignment is proposed. A monolayer SCG with high conductivity and initial anchoring of LC molecules was used as a functional electrode, thus no additional alignment layer is needed, which effectively simplifies the basic structure and process flow of conventional LCMLA. Experiments indicated that a uniform LC alignment can be acquired in the EC-LCMLA cell by the SCG coupling alignment effect. The common optical properties including focal lengths and point spread function (PSF) were measured experimentally. Experiments demonstrated that the proposed EC-LCMLA has good focusing performance in the visible to near-infrared range. Moreover, the plenoptic imaging in Galilean mode was achieved by integrating the proposed EC-LCMLA with photodetectors. Digital refocusing was performed to obtain a rendering image of the target.
Collapse
|
111
|
Shi X, Hu C, Cai S, Tao X, Zhou Y, Smidt H, Ye B. Protective effects of Lactobacillus plantarum strain P1 against toxicity of the environmental oestrogen di-n-butyl phthalate in rats. Benef Microbes 2020; 11:803-813. [PMID: 33191779 DOI: 10.3920/bm2019.0181] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Phthalates are contaminants widely distributed in the food-chain, and they are considered as important environmental oestrogens in our lives. In the present study, eight strains of lactic acid bacteria were isolated for their ability to adsorb di-n-butyl-phthalate (DBP), and one of the strains, Lactobacillus plantarum strain P1, was selected for more detailed analyses of its phthalate adsorption capacity in vitro. This study also evaluated the in vivo protective effects of strain P1 against DBP toxicity in rats. Sixteen rats were divided into four groups, and animals received by oral gavage every other day for a period of one month saline with or without strain P1 at 2×1011 cfu/kg followed by maize oil with or without DBP (50 mg/kg). Strain P1 could adsorb more DBP than saline alone, and the concentration of mono-n-butyl phthalate in urine was decreased in animals receiving P1. Furthermore, oestrogenic effects of the different treatments were assessed through counting of sperm and observation of testis, and strain P1 could protect the sexual organs of male rats. Our results suggested that P1 is effective against phthalate toxicity due to its ability to adsorb DBP in vivo and could be considered as a new dietary therapeutic strategy against environmental phtalate toxicity.
Collapse
|
112
|
Shen C, Zhou X, Yang Y, Hu C. Body Composition As A Predictor Of Critical Toxicities In Patients With Locoregionally Nasopharyngeal Carcinoma Undergoing Neoadjuvant Chemotherapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
113
|
Wu YL, Zhang L, Fan Y, Zhou J, Zhang L, Zhou Q, Li W, Hu C, Chen G, Zhang X, Zhou C, Souza F, Lin J, Wang J, Li B, Mok T. 389P Updated analysis from the KEYNOTE-042 China study: 1L pembrolizumab (pembro) vs chemotherapy (chemo) in Chinese patients (pts) with advanced NSCLC with PD-L1 TPS ≥1%. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.10.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
114
|
Ou D, Wang X, Xue F, Niu X, Liu P, He X, Hu C. Is Nasopharyngeal Carcinoma In Young Patients A Distinct Clinical Entity? A Single-Institution Case Matched Analysis In The Era Of Intensity-Modulated Radiotherapy. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
115
|
Guo Y, Yang Q, Hu W, Zhang Z, Wang J, Hu C. Automatic Segmentation Of Nasopharyngeal Carcinoma On MR Images: A Single-Institution Experience. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
116
|
Smith R, Mahnert N, Hu C, Steck-Bayat K, Womack A, Mourad J. Impact of Retained Cystoscopy Fluid Following Laparoscopic Hysterectomy: A Randomized Controlled Trial. J Minim Invasive Gynecol 2020. [DOI: 10.1016/j.jmig.2020.08.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
117
|
Cai M, Yang Q, Guo Y, Zhang Z, Wang J, Hu W, Hu C. Combining Images and Clinical Diagnostic Information to Improve Automatic Segmentation of Nasopharyngeal Carcinoma Tumors on MR Images. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
118
|
Rimner A, Hu C, Zauderer M, Yorke E, Simone C, Gill R, Voong K, Peikert T, Tsao M, Li Z, Rusch V, Bradley J. A Phase III Randomized Trial of Pleurectomy/Decortication Plus Chemotherapy With Or Without Adjuvant Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) For Malignant Pleural Mesothelioma (MPM) (NRG-LU006). Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.583] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
119
|
Ou X, Shen C, He X, Hu C. Germline Mutation Landscape of DNA Damage Repair Genes in Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.2168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
120
|
Lyu Y, Ni M, Zhai R, Kong F, Du C, Hu C, Ying H. Clinical Characteristics and Prognosis of Elderly Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy Only. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.366] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
121
|
Guo Y, Yang Q, Hu W, Zhang Z, Wang J, Hu C. Automatic T-staging Using Weakly Supervised Deep Learning For Nasopharyngeal Carcinoma On MR Images. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
122
|
Xu K, BI N, Ge H, E M, Zhang L, Cao J, Zhang X, Xia B, Zhao L, Li J, Hu C, Wang L. Real-World Analysis of Clinical Characters, Prognosis, And Recurrence Pattern: A Retrospective Multicenter Study of 429 Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC). Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.1173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
123
|
Lam V, Hales R, Feliciano J, Voong K, Shin E, Smith K, Anagnostou V, Velculescu V, Thompson E, Sears C, Pardoll D, Rodavia H, Schneider H, Hu C, Amjad A, Guerrieri P, Jobe B, Zaidi A, Kelly R. 1497TiP REACTION – a phase Ib pilot study of nivolumab or nivolumab in combination with relatlimab after targeted radiation in patients with advanced esophagogastric cancer. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
124
|
Zhang L, Zhao H, Zhang Z, Yao W, Min X, Gu K, Yu G, Cheng C, Cui J, Miao L, Song X, Zhang L, Yuan X, Fang Y, Fu X, Hu C, Zhu X, Fan Y, Yu Q. LBA50 ACTIVE: Apatinib plus gefitinib versus placebo plus gefitinib as first-line treatment for advanced epidermal growth factor receptor-mutant (EGFRm) non-small-cell lung cancer (NSCLC): A multicentered, randomized, double-blind, placebo-controlled phase III trial (CTONG1706). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.2283] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
125
|
Wang J, Lu S, Hu C, Sun Y, Yang K, Chen M, Zhao J, Yu G, Zhou X, Feng G, Pan Y, Yu Y, Zhang J, Liang L, Lin X, Wu X, Cui J. 1264P Updated analysis of tislelizumab plus chemotherapy vs chemotherapy alone as first-line treatment of advanced squamous non-small cell lung cancer (SQ NSCLC). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1578] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|